Upcoming Events

Press Releases

Date

2008 Press Releases

2005

2004

2003

	10/07/08	Arbios Sells HepatAssist Bioartificial Liver System to HepaLife Technologies, Inc.
	08/05/08	Arbios Announces It Has Suspended Operations
	05/12/08	Arbios Receives Approval from the FDA to Initiate Pivotal Trial for SEPET™ Liver Assist Device
	04/15/08	Arbios Commences Process to Seek European Marketing Approval for SEPET™
	02/22/08	Arbios Receives Conditional Approval from the FDA to Initiate Pivotal Clinical Trial for SEPET™
	10/31/07	Arbios to Present at Acumen Biofin Rodman & Renshaw 9^th Annual Healthcare Conference
	10/23/07	Arbios Announces SEPET™ Manufacturing with NxStage Medical
	10/01/07	Arbios Clinical Update - October 2007
	10/01/07	Arbios Corporate Presentation - October 2007
	09/25/07	Arbios Provides Clinical Strategy for SEPET™ Pivotal Trial
	09/20/07	Arbios Systems Announces Exclusive Supply Agreement with Membrana GmbH for Blood Filtration Membranes
	09/19/07	Arbios Announces Management Changes
	09/07/07	Arbios Systems Publishes Positive Results from Completed SEPET™ Feasibility Clinical Trials
	04/23/07	Arbios Raises $4.8 Million to Advance Its SEPET™ Liver Assist Device into Pivotal Clinical Trials
	04/02/07	Arbios Systems Reports Favorable Results from the SEPET™ Feasibility Clinical Trial
	03/30/07	Arbios Systems Strengthens Its Propietary Position for Blood Filtration Therapies in Critical Care Medicine
	01/18/07	Arbios Systems, Inc. Informational Review Issued by Scimitar Equity Research, Inc.
	12/05/06	Arbios Systems Chief Scientific Officer Presents at the Acute Liver Failure Workshop, Sponsored by the NIH
	11/15/06	Arbios Systems Announces Addition of Senior Personnel
	11/02/06	Arbios Systems to Present at the Rodman & Renshaw 8^th Annual Healthcare Conference
	10/27/06	Arbios Systems Announces Presentation of SEPET™ Clinical Data at the 57^th Annual AASLD Meeting
	09/29/06	Arbios Granted FDA Allowance to Expand SEPET™ Clinical Trial Eligibility
	07/06/06	Arbios Adds University of California at San Francisco (UCSF) as Fourth Participating Site in the Sepet™ Clinical Feasibility Trial
	06/23/06	Arbios Founder and Chief Scientific Officer, Jacek Rozga, Invited to Present the SEPET™ Liver Assist Device at the Annual Conference of the European Society of Artificial Organs
	05/15/06	Arbios Systems Presents Positive Interim Safety and Patient Outcome Results from the SEPET™ Liver Assist Device Clinical Trial
	05/08/06	Arbios Systems Presentation at Rodman & RenShaw Techvest 3rd Annual Global Healthcare Conference to be Webcast Live
	04/10/06	Arbios to Present at Bio 2006 Chicago Annual International Convention on Tuesday, April 11th at 9:00am Central Time
	03/22/06	Arbios Receives FDA Allowance to Increase Patient Enrollment for SEPET™ Clinical Trial and Adds Major Liver Center as a Third Participating Site. The University of California at San Diego (UCSD) Medical Center Begins Patient Recruitment
	03/13/06	Arbios Expands Indications for SEPET™ Feasibility Trial, Company also Provides an Update of its Clinical Development Program
	03/06/06	Arbios Raises $1.35 Million in Private Placement
	02/03/06	Arbios Systems Appoints Richard W. Bank, M.D. to the Board of Directors